Erratum: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors (Cancer Res (2022) 82 (484–496) DOI: 10.1158/0008-5472.CAN-21-1621)

Ellen M. Westerhout, Mohamed Hamdi, Peter Stroeken, Natalia E. Nowakowska, Arjan Lakeman, Jennemiek van Arkel, Nancy E. Hasselt, Boris Blejlevens, Nurdan Akogul, Franciska Haneveld, Alvin Chan, Peter van Sluis, Danny Zwijnenburg, Richard Volckmann, Carel J. M. van Noesel, Igor Adameyko, Tim van Gronigen, Jan Koster, Linda J. Valentijn, Johan van NesRogier Versteeg

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

In the original version of this article (1), there was an issue in Fig. 2B. Specifically, some of the Western blot bands showing expression of DBH, DLK1, PRRX1, SNAI2, and b-actin in the 691-MES/691-ADRN and SH-EP2/SH-SY5Y isogenic neuroblastoma cell lines were previously used in Fig. 1B of a publication by the authors (2). The legend for Fig. 2 has been updated in the latest online HTML and PDF versions of the article (1) to include a citation to the authors’ earlier article in Nature Genetics (2).
Original languageEnglish
Pages (from-to)2657
Number of pages1
JournalCancer research
Volume82
Issue number14
DOIs
Publication statusPublished - 15 Jul 2022

Cite this